Browsing by Author "Torre, Carla"
Now showing 1 - 2 of 2
Results Per Page
Sort Options
- Burnout in the pharmaceutical activity: the impact of COVID-19Publication . Santos, Pedro Machado dos; Silva, Cláudia Ribeiro da; Costa, Diana; Torre, CarlaImportance: Pharmacists are among the healthcare professionals involved in the response to the COVID-19 pandemic, maintaining essential services. In the context of restrictions and reorganization of human resources, as a result of policies recently applied to the health sector, following international guidelines, and given the scarcity of data on burnout in pharmaceutical activity, it was considered highly relevant to promote a nationwide survey aiming to collect more complete evidence on the burnout syndrome and to understand how pharmacists have viewed their work and the people they worked closely with. Objectives: The study aimed to assess the occurrence of pharmacist burnout and determine outcomes for each of its dimensions; identify potentially associated characteristics; and determine profiles and critical limits. Design: A cross-sectional observational study conducted by a multidisciplinary panel from the Portuguese Pharmaceutical Society (PPS). Professionals from community and hospital pharmacies who were at the forefront of the COVID-19 response were involved in (i) confirming the need and pertinence for conducting this research, (ii) identifying the main factors leading to pharmaceutical emotional distress (“burnout”), and (iii) disseminating the survey. The questionnaire was designed for digital voluntary, confidential, and anonymous participation and divided into four segments of data collection: (i) demographics, (ii) employment and workplace characterization, (iii) pandemic impact on labor activity, and (iv) burnout assessment (as described ahead). Setting: An electronic survey was addressed to all PPS members, and an account was created solely to manage the questionnaire data for the research team. The web-based and user-friendly platform Google Forms supported the data capture and provided an intuitive interface for validated data entry. Participants: In a population of 15,565 pharmacists (members of the PPS), the minimum recommended sample size (Epi Info software), with a 5% margin of error and a 99.9% confidence interval, should be 1,012 individuals. A total of 1,362 pharmacists participated in the study. Of these, 91.4% (n = 1,246) were involved in direct patient care activity and 7.7% (n = 106) in non-direct patient care activity.
- Perfil Terapêutico da Hipertensão na rede Médicos Sentinela : 12 Anos DepoisPublication . Souto, Diana; Simões, José Augusto; Torre, Carla; Mendes, Zilda; Falcão, Isabel Marinho; Ferreira, Fernando; Miranda, Ana da Costa; Dias, Carlos MatiasObjectives: To determine the treatment profile of hypertension in theQPortuguese sentinel practice network and compare the results 12 years after an initial study. Study design: Cross-sectional study Setting: Portuguese sentinel practice network Participants: Hypertensive patients over 18 years of age on the lists of general practitioners in the sentinel practice network who attended a consultation with their physician between June 7, 2010 and December 31, 2010. Results: In 2010, 616 hypertensive patients were included in the study. Between the two periods (1998 and 2010) there was a slight increase in the average age of the participants (62.0 years in 1998 and 64.3 years in 2010), with a higher proportion of female patients in both periods. The meanQaverage duration of hypertension since the time of diagnosis increased significantly (<0.0001). Approximately half of the hypertensive patients presented target organ damage, in both periods with heart disease as the most common lesion. Dyslipidemia, hyperuricemia and diabetes were the most common co-morbid conditions. From 1998 to 2010, the proportion of patients on monotherapy decreased from 47.6% to 30.3%. Angiotensin-converting enzyme inhibitors were the most frequently prescribed drugs for monotherapy in both periods. In 1998, the antihypertensive treatment most frequently prescribed was angiotensin-converting enzyme inhibitors as monotherapy (24.3%). In 2010 the combination of angiotensin receptor blockers with thiazide diuretics was the most common treatment (15.4%). Conclusions: Drugs acting on the renin-angiotensin system were the antihypertensive drugs most frequently prescribed in both periods as monotherapy and in combination with other drugs. The number of antihypertensive drugs prescribed differed between the two periods in relation to the existence and type of co-morbidities.